These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 22241994)
1. Human subtilase SKI-1/S1P is a master regulator of the HCV Lifecycle and a potential host cell target for developing indirect-acting antiviral agents. Olmstead AD; Knecht W; Lazarov I; Dixit SB; Jean F PLoS Pathog; 2012 Jan; 8(1):e1002468. PubMed ID: 22241994 [TBL] [Abstract][Full Text] [Related]
2. Human Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P) regulates cytoplasmic lipid droplet abundance: A potential target for indirect-acting anti-dengue virus agents. Hyrina A; Meng F; McArthur SJ; Eivemark S; Nabi IR; Jean F PLoS One; 2017; 12(3):e0174483. PubMed ID: 28339489 [TBL] [Abstract][Full Text] [Related]
3. SKI-1/S1P inhibitor PF-429242 impairs the onset of HCV infection. Blanchet M; Sureau C; Guévin C; Seidah NG; Labonté P Antiviral Res; 2015 Mar; 115():94-104. PubMed ID: 25573299 [TBL] [Abstract][Full Text] [Related]
4. The Hepatitis C Virus-induced NLRP3 Inflammasome Activates the Sterol Regulatory Element-binding Protein (SREBP) and Regulates Lipid Metabolism. McRae S; Iqbal J; Sarkar-Dutta M; Lane S; Nagaraj A; Ali N; Waris G J Biol Chem; 2016 Feb; 291(7):3254-67. PubMed ID: 26698881 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic inhibition of site 1 protease activity inhibits sterol regulatory element-binding protein processing and reduces lipogenic enzyme gene expression and lipid synthesis in cultured cells and experimental animals. Hawkins JL; Robbins MD; Warren LC; Xia D; Petras SF; Valentine JJ; Varghese AH; Wang IK; Subashi TA; Shelly LD; Hay BA; Landschulz KT; Geoghegan KF; Harwood HJ J Pharmacol Exp Ther; 2008 Sep; 326(3):801-8. PubMed ID: 18577702 [TBL] [Abstract][Full Text] [Related]
6. Gene set enrichment analysis reveals several globally affected pathways due to SKI-1/S1P inhibition in HepG2 cells. De Windt A; Rai M; Bernier L; Thelen K; Soini J; Lefebvre C; Chintawar S; Lavigne J; Saarinen L; Kytömäki L; Munzer JS; Lütjohann D; Pandolfo M; Davignon J; Seidah NG; Laaksonen R DNA Cell Biol; 2007 Nov; 26(11):765-72. PubMed ID: 17867930 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus stimulates low-density lipoprotein receptor expression to facilitate viral propagation. Syed GH; Tang H; Khan M; Hassanein T; Liu J; Siddiqui A J Virol; 2014 Mar; 88(5):2519-29. PubMed ID: 24352472 [TBL] [Abstract][Full Text] [Related]
8. Targeting the proteolytic processing of the viral glycoprotein precursor is a promising novel antiviral strategy against arenaviruses. Rojek JM; Pasqual G; Sanchez AB; Nguyen NT; de la Torre JC; Kunz S J Virol; 2010 Jan; 84(1):573-84. PubMed ID: 19846507 [TBL] [Abstract][Full Text] [Related]
9. The proprotein convertase SKI-1/S1P is a critical host factor for Nairobi sheep disease virus infectivity. Bost C; Hartlaub J; Pinho Dos Reis V; Strecker T; Seidah NG; Groschup MH; Diederich S; Fischer K Virus Res; 2023 May; 329():199099. PubMed ID: 36948228 [TBL] [Abstract][Full Text] [Related]
10. SKI-1/S1P inhibition: a promising surrogate to statins to block hepatitis C virus replication. Blanchet M; Seidah NG; Labonté P Antiviral Res; 2012 Aug; 95(2):159-66. PubMed ID: 22626636 [TBL] [Abstract][Full Text] [Related]
11. Suppressive Effects of the Site 1 Protease (S1P) Inhibitor, PF-429242, on Dengue Virus Propagation. Uchida L; Urata S; Ulanday GE; Takamatsu Y; Yasuda J; Morita K; Hayasaka D Viruses; 2016 Feb; 8(2):. PubMed ID: 26875984 [TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of the processing of arenavirus envelope glycoprotein precursors by subtilisin kexin isozyme-1/site-1 protease. Burri DJ; Pasqual G; Rochat C; Seidah NG; Pasquato A; Kunz S J Virol; 2012 May; 86(9):4935-46. PubMed ID: 22357276 [TBL] [Abstract][Full Text] [Related]
13. A Molecular Sensor To Characterize Arenavirus Envelope Glycoprotein Cleavage by Subtilisin Kexin Isozyme 1/Site 1 Protease. Oppliger J; da Palma JR; Burri DJ; Bergeron E; Khatib AM; Spiropoulou CF; Pasquato A; Kunz S J Virol; 2016 Jan; 90(2):705-14. PubMed ID: 26512085 [TBL] [Abstract][Full Text] [Related]
14. Recombinant expression, purification, and kinetic and inhibitor characterisation of human site-1-protease. Bodvard K; Mohlin J; Knecht W Protein Expr Purif; 2007 Feb; 51(2):308-19. PubMed ID: 16973377 [TBL] [Abstract][Full Text] [Related]
15. Novel circular, cyclic and acyclic Ψ(CH(2)O) containing peptide inhibitors of SKI-1/S1P: synthesis, kinetic and biochemical evaluations. Majumdar S; Chen A; Palmer-Smith H; Basak A Curr Med Chem; 2011; 18(18):2770-82. PubMed ID: 21568902 [TBL] [Abstract][Full Text] [Related]
16. Site-1 protease, a novel metabolic target for glioblastoma. Caruana BT; Skoric A; Brown AJ; Lutze-Mann LH Biochem Biophys Res Commun; 2017 Aug; 490(3):760-766. PubMed ID: 28645614 [TBL] [Abstract][Full Text] [Related]
17. Reduced sterol regulatory element-binding protein (SREBP) processing through site-1 protease (S1P) inhibition alters oligodendrocyte differentiation in vitro. Monnerie H; Romer M; Jensen BK; Millar JS; Jordan-Sciutto KL; Kim SF; Grinspan JB J Neurochem; 2017 Jan; 140(1):53-67. PubMed ID: 27385127 [TBL] [Abstract][Full Text] [Related]
18. Differential recognition of Old World and New World arenavirus envelope glycoproteins by subtilisin kexin isozyme 1 (SKI-1)/site 1 protease (S1P). Burri DJ; da Palma JR; Seidah NG; Zanotti G; Cendron L; Pasquato A; Kunz S J Virol; 2013 Jun; 87(11):6406-14. PubMed ID: 23536681 [TBL] [Abstract][Full Text] [Related]
19. Cartilage-specific ablation of site-1 protease in mice results in the endoplasmic reticulum entrapment of type IIb procollagen and down-regulation of cholesterol and lipid homeostasis. Patra D; DeLassus E; Liang G; Sandell LJ PLoS One; 2014; 9(8):e105674. PubMed ID: 25147951 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis C Virus Increases Occludin Expression via the Upregulation of Adipose Differentiation-Related Protein. Branche E; Conzelmann S; Parisot C; Bedert L; Lévy PL; Bartosch B; Clément S; Negro F PLoS One; 2016; 11(1):e0146000. PubMed ID: 26731658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]